| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Reynoso Jamie L. | CEO, Medicare Advantage | C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON | /s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso | 05 Jan 2026 | 0001839066 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLOV | Class A Common Stock | Tax liability | $19,543 | -8,109 | -0.29% | $2.41 | 2,759,131 | 03 Jan 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 3, 2026, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date. |